NewsScan
A Daily Summary of Healthcare and Business News
11/19/2021 - MetroNews
CHARLESTON, WV - Dr. Rahul Gupta on Thursday was sworn in as the director of the Office of National Drug Control Policy.
A subscription may be necessary to view this article.
11/18/2021 - The Associated Press
WASHINGTON, DC - The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation’s largest purchase agreement yet for a coronavirus therapy.
A subscription may be necessary to view this article.
11/18/2021 - The Hill by: Justine Coleman
WASHINGTON, DC - AstraZeneca found its antibody cocktail to be more than 80 percent effective at preventing symptomatic COVID-19 in a company analysis released on Thursday, a strong result for a treatment that could help immunocompromised people avert severe COVID-19 illness.
A subscription may be necessary to view this article.
11/18/2021 - The Associated Press by: Zeke Miller
WASHINGTON, DC - The White House says about 10% of eligible kids aged 5 to 11 have received a dose of the Pfizer COVID-19 vaccine since its approval for their age group two weeks ago.
A subscription may be necessary to view this article.
11/18/2021 - Charleston Gazette-Mail by: Caity Coyne
CHARLESTON, WV - With 970 new cases and 22 new COVID-19 associated deaths reported in West Virginia on Wednesday — including some reconciliation deaths — state officials are again begging residents to get their vaccines before winter holidays exacerbate the spread.
A subscription may be necessary to view this article.
11/18/2021 - MetroNews
HUNTINGTON, WV - Cabell Huntington Hospital has received a temporary restraining order regarding union-led protests outside of the health care facility.
A subscription may be necessary to view this article.
11/18/2021 - The Associated Press by: Mike Stobbe
NEW YORK, NY - An estimated 100,000 Americans died of drug overdoses in one year, a never-before-seen milestone that health officials say is tied to the COVID-19 pandemic and a more dangerous drug supply.
A subscription may be necessary to view this article.